Your browser doesn't support javascript.
loading
Efficacy of pembrolizumab in a patient with xeroderma pigmentosum variant and advanced cutaneous squamous-cell carcinoma.
Hennemann, Aymeric; Collonge Rame, Marie Agnès; Puzenat, Eve; Ged, Cécile; Harbon, Sylvain; Aubin, François; Nardin, Charlée.
Afiliação
  • Hennemann A; Dermatology Department and Inserm Unit 1098, Franche Comté University and University Hospital, Besancon, France.
  • Collonge Rame MA; Genetic Department, University Hospital, Besancon, France.
  • Puzenat E; Dermatology Department and Inserm Unit 1098, Franche Comté University and University Hospital, Besancon, France.
  • Ged C; Univ. Bordeaux, INSERM, BMGIC, Bordeaux, France.
  • Harbon S; Saint Vincent Clinic, Besançon, France.
  • Aubin F; Dermatology Department and Inserm Unit 1098, Franche Comté University and University Hospital, Besancon, France.
  • Nardin C; Dermatology Department and Inserm Unit 1098, Franche Comté University and University Hospital, Besancon, France.
Acta Oncol ; 61(9): 1140-1142, 2022 09.
Article em En | MEDLINE | ID: mdl-35950634
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Xeroderma Pigmentoso / Carcinoma de Células Escamosas Limite: Humans Idioma: En Revista: Acta Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Xeroderma Pigmentoso / Carcinoma de Células Escamosas Limite: Humans Idioma: En Revista: Acta Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França